CI
XBI icon

CPR Investments’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

CPR Investments’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-21,212
Closed -$2.01M – 56
2024
Q1 		$2.01M Buy
+21,212
New +$1.97M 1.53% 20
2023
Q1 		– Sell
-23,315
Closed -$1.94M – 55
2022
Q4 		$1.94M Buy
+23,315
New +$1.89M 1.92% 15

Other funds holding XBI

JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

CPR Investments's XBI Position: Q2 2024 in Review

CPR Investments sold out of State Street SPDR S&P Biotech ETF (XBI) in Q2 2024, closing a stake of 21,212 shares — an estimated $2.01M sold.

CPR Investments first reported a position in XBI in Q4 2022 and held it in 2 quarters. The position peaked at $2.01M in Q1 2024. 761 funds tracked by Wall St. Rank hold XBI as of Q2 2024.

  • CPR Investments reported no remaining State Street SPDR S&P Biotech ETF position as of Q2 2024 after selling out during the quarter.
  • CPR Investments sold 21,212 State Street SPDR S&P Biotech ETF shares in Q2 2024, an estimated $2.01M.
  • CPR Investments first reported a position in State Street SPDR S&P Biotech ETF in Q4 2022 and held it in 2 quarters.
  • CPR Investments's State Street SPDR S&P Biotech ETF position peaked at $2.01M in Q1 2024.
  • 761 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2024.

Based on CPR Investments's 13F filing for Q2 2024, filed 19 Jul 2024.